SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012612
Filing Date
2017-11-08
Accepted
2017-11-08 17:01:19
Documents
52
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 546410
2 ex31-1.htm EX-31.1 11260
3 ex31-2.htm EX-31.2 10103
4 ex32-1.htm EX-32.1 10370
  Complete submission text file 0001493152-17-012612.txt   2347513

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20170930.xml EX-101.INS 335544
6 XBRL SCHEMA FILE cocp-20170930.xsd EX-101.SCH 31387
7 XBRL CALCULATION FILE cocp-20170930_cal.xml EX-101.CAL 37637
8 XBRL DEFINITION FILE cocp-20170930_def.xml EX-101.DEF 99084
9 XBRL LABEL FILE cocp-20170930_lab.xml EX-101.LAB 202140
10 XBRL PRESENTATION FILE cocp-20170930_pre.xml EX-101.PRE 159121
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55158 | Film No.: 171187365
SIC: 2834 Pharmaceutical Preparations